Skip to main content
. 2019 Jul 5;2019(7):CD011156. doi: 10.1002/14651858.CD011156.pub2

Figueroa 2016.

Methods Study design (CBA, ITS): CBA
Allocation linked to study or natural experiment: natural experiment
Selection of hospitals (intervention/control): comparison 1: all conditions targeted by P4P/selected conditions not targeted by P4P; comparison 2: acute care hospitals/hospitals in another region and critical access hospitals
Unit of allocation (region, hospital, country): comparison 1: individual level; comparison 2: region and hospital type
Nature of desired change: introduction
Data source: 100% Medicare inpatient claims data from 2008 through 2013
Unit of analyses: comparison 1: individual; comparison 2: hospital
Number of measurements (before, transition, after, unit [e.g. years]): 14/NA/10 (quarter)
Statistical analyses:
‐ Method: difference‐in‐difference; random effects linear spline regression
‐ Adjustment factors: comorbidities, seasonal variation
Participants Country/region/setting: USA/whole country/hospitals
Health system characteristics: Medicare
Number of hospitals included in the analysis (intervention/control): 2919/1348
Characteristics of hospitals (before [whole population], intervention/control): acute care hospitals/hospitals in another region and critical access hospitals
  • Number of beds:

    • small: 27.7%/92.7%

    • medium: 57.4%/6.8%

    • large: 13.9%/0.6%

  • Number of patients (mean annual Medicare volume): 2671/385

  • Number of wards: NR

  • Departments: NR

  • Owner:

    • For profit: 20.4%/5.3%

    • Private not for profit: 64.8%/54.5%

    • Public: 14.8%/40.3%

  • Teaching status:

    • major: 9.0%/0.5%

    • minor: 24.0%/6.4%

    • none: 67.1%/93.2%

  • Location: NR


Number of patients included in the analysis (intervention/control): 2,252,818/177,800
Characteristics of patients (intervention/control): acute
myocardial infarction, congestive heart failure, and pneumonia/stroke, sepsis, gastroenteritis and esophagitis, gastrointestinal bleed, urinary tract infection, metabolic disorder, arrhythmia, renal failure
  • Age (mean): 79.8/81.0

  • Gender (male): 42.1%/39.5%

  • Casemix: NR

  • Indications: NR


Existing/other quality programs: not reported
Other relevant context information: none
Interventions Rewards or penalizes hospitals based on their performance on multiple domains of care, including clinical processes, clinical outcomes (e.g. 30‐day mortality for acute myocardial infarction, pneumonia, and heart failure), patient experience, and, latter, cost efficiency.
Performance is determined based on hospitals’ absolute achievement compared with the national average, or improvement compared with their own performance in the baseline period, depending on which is greater.
Funding is designed to be budget neutral; Medicare withholds a percentage of inpatient payments to prospectively paid hospitals and then redistributes this money back to hospitals based on their performance.
National in scope and obligatory.
Control:
Comparison 1: No P4P
Comparison 2: Probably mixture of basic P4P (incentives of hospitals without penalties) and no P4P
Outcomes Mortality (30 days)
Notes Funding/conflict of interest: work received no support from any organization; authors no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work
Information for subgroup analysis: low baseline performance
Other comments: ‐
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk CBA
Allocation concealment (selection bias) High risk CBA
Blinding of participants and personnel (performance bias) 
 All outcomes High risk CBA, intervention cannot be blinded
Blinding of outcome assessment (detection bias) 
 Objective outcomes Low risk Mortality
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Not sufficiently reported
Selective reporting (reporting bias) Low risk No indication for selective reporting
Other bias Low risk No evidence of other risk of bias
Baseline outcomes similar 
 All outcomes High risk Difference in baseline outcomes
Free of contamination High risk Comparison 1: high risk, allocation on individual level and intervention cannot be blinded
Comparison 2: low risk, allocation on hospital level
Baseline characteristics similar High risk Difference in baseline characteristics